InnovAge Holding Corp.
HealthcareNASDAQ:INNV · NASDAQ Global Select
-$0.04 today
Vol 0.36M · Avg 0.29M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-12.9%
avg 0.2%
ROIC
-7.4%
avg 2.0%
ROA
-5.4%
avg -2.0%
Analysis
ROA is currently the strongest return metric at -5.4% versus its period average of -2.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Patrick Blair | Chief Executive Officer | $1.55M | — | 55 | $687,103.00 | 0.51% |
Nicole D'Amato | Chief Legal Officer & Corporate Secretary | $766,120.00 | — | 47 | $296,743.00 | 0.22% |
Benjamin Crowninshield Adams | Chief Financial Officer | $699,665.00 | — | 62 | $0.00 | <0.01% |
Marilyn Barbour Tavenner | Independent Director | $100,000.00 | — | 74 | $45,157.00 | 0.03% |
Edward Moore Kennedy Jr. | Independent Director | $100,000.00 | — | 65 | $68,157.00 | 0.05% |
Ryan Kubota | Director of Investor Relations | — | — | — | — | — |
Cara Babachicos | Chief Information Officer | — | — | — | — | — |
Meredith Delk | Executive Vice President & Chief Administrative Officer | — | — | 53 | $0.00 | <0.01% |
Olivia Patton | Chief Compliance Officer | — | — | — | — | — |
Dustin Lee | Chief People Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
1
$161,700.00
Net Sentiment
$161,700.00
Net selling
Most Active
SCARBROUGH MICHAEL ANTHONY
1 transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | SCARBROUGH MICHAEL ANTHONY Direct | Sell | 33.0K | $4.90 | $161,700.00 |
Analysis
Insiders reported 0 buys worth $0.00 and 1 sells worth $161,700.00 over the last 12 months. That adds up to net selling of $161,700.00. SCARBROUGH MICHAEL ANTHONY was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +6.7% | +10.0% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +6.7% over three years. Forward estimates point to Revenue at +10.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
SI-BONE, Inc.
NASDAQ:SIBN
$683.87M
Community Health Systems, Inc.
NYSE:CYH
$439.66M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$414.11M
AirSculpt Technologies, Inc.
NASDAQ:AIRS
$377.42M
Orthofix Medical Inc.
NASDAQ:OFIX
$376.33M
Anavex Life Sciences Corp.
NASDAQ:AVXL
$231.68M
DarioHealth Corp.
NASDAQ:DRIO
$51.63M
Who manages INNV?
InnovAge Holding Corp. (INNV) lists 10 active executives. The top listed executive is Marilyn Barbour Tavenner, Independent Director.
Are INNV insiders buying or selling?
Recent insider activity shows net buying of $10.15M.
Explore More
Continue the stock analysis
Jump to another research area for this company.